| Trial ID: | L0645 |
| Source ID: | IRCT201202014010N7
|
| Associated Drug: |
Resveratrol
|
| Title: |
Evaluating the effect of Resveratrol supplement on lipid profile, hepatic enzymes, inflammatory factors, and hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver. <br>Inflammatory liver disease, unspecified;Inflammatory liver disease, unspecified
|
| Interventions: |
Intervention 1: Intervention: Soft gel Resveratrol 500 mg once a day /12 weeks. Intervention 2: Placebo: Edible paraffin soft gelonce a day/ 12 weeks.;Treatment - Drugs;Placebo;Intervention: Soft gel Resveratrol 500 mg once a day /12 weeks;Placebo: Edible
|
| Outcome Measures: |
Liver Enzymes. Timepoint: at the first and at the 12th week of the study. Method of measurement: Biochemical analysis.Liver fibrosis. Timepoint: at the first and the end of the study. Method of measurement: Fibroscan.
|
| Sponsor/Collaborators: |
National Nutrition and Food Technology Research Institute
|
| Gender: |
All
|
| Age: |
18 years65 years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
50
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
11/01/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/4188
|
